Wang, Jingjing
Wang, Ying
He, Yan
Guan, Hui
He, Ling
Mu, Xiaoli
Peng, Xingchen http://orcid.org/0000-0001-7042-718X
Funding for this research was provided by:
National Natural Science Foundation of China (81672386, 81402494)
Sichuan University (H20182240254)
Article History
Received: 25 March 2019
Accepted: 23 September 2019
First Online: 21 November 2019
Ethics approval and consent to participate
: The trial protocol was registered on 13 March 2018 by the Chinese Clinical Trial Registry (ChiCTR1800015199). Central ethical approval has been confirmed from the Chinese Ethics Committee of Registering Clinical Trials (approval no. ChiECRCT-20180033) on 4 April 2018, and we will not begin recruiting at other centers in the trial until local ethical approval has been obtained. All participants have to provide a signed written ICF before enrollment.
: No personal identifying information will be published. Written informed consent must be acquired from all patients or their legal representatives for their clinical data to be published.
: The authors declare that they have no competing interests.